16 May 2023
Quin Hillyer, Political Commentator and Contributing Writer to the Washington Examiner, discusses a recently released report that exposes how there are now more federal agents with arrest and firearm authority (200,000) than U.S. Marines (186,000), the frightening over-arming federal domestic agencies, such as the IRS, with tactical combat gear, body armor and night vision weaponry, and more.
0:00
0:00
Related Podcasts
28 August 2026
Phil Kerpen, Founder and President of American Commitment, discusses the Inflation Reduction Act’s drug price controls, how they hurt access and innovation, and why they must be repealed and replaced with pro-growth policies and strong intellectual property protections to encourage investment in new life-saving medicines.
14 May 2026
Jeremy Nighohossian, Senior Fellow and Economist at the Competitive Enterprise Institute, discusses positive developments in healthcare, including changes in drug development, what the resignation of FDA Commissioner Marty Makary may mean for healthcare policy, and why Certificate of Need (CON) laws impede free market competition and access to care.
24 September 2025
Karen Kerrigan, President and CEO of the Small Business & Entrepreneurship Council, discusses the Trump administration’s AI Action Plan for America, what it means for small businesses and entrepreneurs, and how embracing and investing in AI builds on America's AI dominance.
30 January 2025
Phil Kerpen, Founder and President of American Commitment, discusses top of the agenda items for the new Trump Administration, how deregulation can drastically improve the lives of Americans and promote economic growth, and why the federal government should be firing and not hiring.
28 June 2024
Lauren Stewart, Senior Federal Legislative Liaison at Americans for Prosperity and Concerned Veterans for America, discusses how President Biden is attempting to rewrite his record on healthcare, how his policies have resulted in limited access and increased costs for Americans, and how a personal option healthcare plan can provide more choices and more solutions.
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.



